NCCP: A Care Management Intervention for Non-cardiac Chest Pain

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04904198
Collaborator
(none)
3
1
1
9.6
0.3

Study Details

Study Description

Brief Summary

The investigators developed and implemented an eight-week multicomponent care management intervention for non-cardiac chest pain. Team members including a cardiologist, nurse, and psychiatrist. Impressions and recommendations were shared with the patient's primary care physician. Measures of chest pain severity, frequency and impact and measures of psychological health and health-related quality of life were completed at baseline and intervention completion.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Care Management Intervention for non-cardiac chest pain
N/A

Detailed Description

The investigators developed and implemented an eight-week multicomponent care management intervention for non-cardiac chest pain. The care management team consisted of a nurse, cardiologist, and psychiatrist. Following a one-time consultation visit with the cardiologist and nurse, evaluation and treatment recommendations were conveyed to the participant's primary care physician. Then, the nurse completed eight weekly phone calls with the participant to provide support, introduce therapeutic principles, and assist with coordination of care, under the supervision of a psychiatrist. Intervention feasibility was assessed on several domains including adherence, recruitment, attrition, safety, and data collection. To examine preliminary efficacy, participants completed Likert scales of chest pain symptom severity, frequency and impact, and measures of psychological health (Patient Health Questionnaire-9, General Anxiety Disorder-7, Patient Health Questionnaire-15) and health-related quality of life (12-Item Short Form Survey) at baseline and intervention completion.

Study Design

Study Type:
Interventional
Actual Enrollment :
3 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Care Management Intervention for Non-cardiac Chest Pain: Intervention Development and Feasibility Assessment
Actual Study Start Date :
Mar 22, 2019
Actual Primary Completion Date :
Jan 8, 2020
Actual Study Completion Date :
Jan 8, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Care Management Intervention for Non-cardiac chest pain

Multicomponent care management intervention.

Behavioral: Care Management Intervention for non-cardiac chest pain
Multicomponent eight-week care management intervention involving a consultation visit with a cardiologist and nurse. Recommendations from the consultation visit are conveyed to the primary care physician. Following the visit, the participant has eight weekly phone calls with a nurse to provide support, introduce therapeutic principals, and assess symptoms. The study nurse is supervised by a psychiatrist.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of adherence [Week 8]

    A priori, feasible adherence was defined as 100% completion of the consultation visit and a mean completion of at least half of the eight phone calls over the eight-week study period.

Secondary Outcome Measures

  1. Feasibility of recruitment [Baseline]

    Collect data on the proportion of individuals interested in the study who meet eligibility criteria for participation

  2. Feasibility of intervention attrition [Week 8]

    A priori, an attrition rate of less than or equal to 15% was defined as indicating intervention feasibility

  3. Feasibility of intervention safety [Week 8]

    Any adverse psychological or physical symptoms were documented throughout the study intervention with appropriate follow-up to ensure safety

  4. Feasibility of data collection at baseline [Baseline]

    Assessment of whether participants would be able to complete all baseline study measures

  5. Feasibility of data collection at follow-up [Week 8]

    Assessment of whether participants would be able to complete all follow-up study measures

  6. Change in chest pain symptom severity [Change from baseline at week 8]

    Likert scale from 0 (no pain) to 10 (severe pain)

  7. Change in chest pain symptom frequency [Change from baseline at week 8]

    Likert scale from 0 (infrequent) to 10 (very frequent)

  8. Change in chest pain symptom impact [Change from baseline at week 8]

    Likert scale from 0 (no impact) to 10 (severe impact)

  9. Change in depressive symptoms [Change from baseline at week 8]

    Patient Health Questionnaire-9, score range of 0-27, higher numbers reflect more severe symptoms.

  10. Change in anxiety symptoms [Change from baseline at week 8]

    General Anxiety Disorder-7, score range of 0-21, higher numbers reflect more severe symptoms.

  11. Change in somatic symptom disorder/somatization symptoms [Change from baseline at week 8]

    Patient Health Questionnaire-15, score range of 0-30, higher numbers reflect more severe symptoms.

  12. Change in health-related quality of life [Change from baseline at week 8]

    12-Item Short Form Survey. Generates a physical health composite summary and a mental health composite summary. The mean score is set to 50 for each composite score. Scores > 50 indicate better physical or mental health-related quality of life than the mean, and scores < 50 indicate worse physical or mental health-related quality of life than the mean.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Diagnosis of non-cardiac chest pain, defined as chest pain recurring at least once per week for two weeks with at least two of the following objective tests: (1) electrocardiogram without ischemic changes; (2) negative cardiac enzymes; (3) non-ischemic cardiac stress test.

  • Primary care physician affiliated with the institution

Exclusion Criteria:
  • History or subsequent diagnosis of cardiac disease

  • Objectively diagnosed alternative medical etiology of chest pain (e.g., gastroesophageal disease)

  • Resolution of chest pain prior to enrollment

  • Cognitive impairment, assessed using a six-item screen

  • Inability to communicate in English

  • Lack of telephone access (precluding weekly phone call participation).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jeff Huffman Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Jeff C Huffman, M.D., Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jeff C. Huffman, MD, Associate Chief of Psychiatry, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT04904198
Other Study ID Numbers:
  • 2017P002331
First Posted:
May 27, 2021
Last Update Posted:
May 27, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jeff C. Huffman, MD, Associate Chief of Psychiatry, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 27, 2021